The impact of infliximab therapy on intestinal mucosal expression of matrix metalloproteinase and ADAM genes in patients with inflammatory bowel disease.

Arijs, I.; Lemaire, K.; Quintens, R.; Van Lommel, L.; Perrier, C.; Van Steen, Kristel; De Hertogh, G.; Van Assche, G.; Vermeire, S.; Geboes, K.; Schuit, F.; Rutgeerts, P.

Other (Scientific journals)

Arijs, I.; Lemaire, K.; Quintens, R. et al.

2009 • In Gut

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/56483

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Arijs2009_MMPs and ADAMs_gut to appear.pdf

Author preprint (16.41 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Gastroenterology & hepatology

Author, co-author :

Arijs, I.

Lemaire, K.

Quintens, R.

Van Lommel, L.

Perrier, C.

Van Steen, Kristel ; Université de Liège - ULiège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Bioinformatique

De Hertogh, G.

Van Assche, G.

Vermeire, S.

Geboes, K.

Schuit, F.

Rutgeerts, P.

Language :

English

Title :

The impact of infliximab therapy on intestinal mucosal expression of matrix metalloproteinase and ADAM genes in patients with inflammatory bowel disease.

Publication date :

2009

Journal title :

Gut

ISSN :

0017-5749

eISSN :

1468-3288

Publisher :

BMJ Group, London, United Kingdom

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 26 May 2010

Statistics

Number of views

43 (4 by ULiège)

Number of downloads

3 (1 by ULiège)

More statistics